Beacon Pointe Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,448
Closed -$217K 1172
2023
Q1
$217K Sell
4,448
-209
-4% -$10.6K ﹤0.01% 1036
2022
Q4
$246K Buy
4,657
+54
+1% +$2.66K ﹤0.01% 935
2022
Q3
$201K Sell
4,603
-610
-12% -$30.1K ﹤0.01% 928
2022
Q2
$260K Sell
5,213
-472
-8% -$23K 0.01% 880
2022
Q1
$295K Buy
+5,685
New +$293K ﹤0.01% 985
2021
Q4
Sell
-4,117
Closed -$226K 988
2021
Q3
$226K Sell
4,117
-178
-4% -$9.91K 0.01% 811
2021
Q2
$220K Buy
+4,295
New +$222K 0.01% 766

Other funds holding QGEN

Beacon Pointe Advisors's QGEN Position: Q2 2023 in Review

Beacon Pointe Advisors sold out of Qiagen (QGEN) in Q2 2023, closing a stake of 4,448 shares — an estimated $217K sold.

Beacon Pointe Advisors first reported a position in QGEN in Q2 2021 and held it in 7 quarters. The position peaked at $295K in Q1 2022. 282 funds tracked by Wall St. Rank hold QGEN as of Q2 2023.

  • Beacon Pointe Advisors reported no remaining Qiagen position as of Q2 2023 after selling out during the quarter.
  • Beacon Pointe Advisors sold 4,448 Qiagen shares in Q2 2023, an estimated $217K.
  • Beacon Pointe Advisors first reported a position in Qiagen in Q2 2021 and held it in 7 quarters.
  • Beacon Pointe Advisors's Qiagen position peaked at $295K in Q1 2022.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q2 2023.

Based on Beacon Pointe Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.